This document reinforces the five essential elements of the DOTS strategy.
Favorite
International Agencies
2002
This booklet answers questions about the 4-drug fixed-dose combinations containing 150 mg rifampicin, 75 mg isoniazid, 400 mg pyrazinamide, and 275 mg ethambutol that were added to the WHO Model List of Essential Drugs for the treatment of TB.
Favorite
International Agencies
2002
This group of four fact sheets explain the origin and purpose of the Global Drug Facility (GDF), how the GDF works, how to apply to the GDF for a grant of TB drugs, and how to buy drugs through the GDF.
Favorite
International Agencies
2002
This report explains the European DOTS Expansion plan to control TB. The plan highlights country needs and resource gaps, emphasizing collaboration with the governments of endemic countries, national and international agencies, and nongovernmental organizations (NGOs). The aim is to stimulate social and political commitment to achieving the global TB targets as part of the overall health system...
Favorite
International Agencies
Policy Makers
2002
This book presents five papers that were used as background to a workshop on "Improving TB Drug Management: Accelerating DOTS Expansion" on June 2002, in Washington, DC. The papers address the weaknesses in drug management programs of certain countries and provide a framework for strengthening these programs through country-specific action plans.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2002
This pamphlet discusses taking TB medicines, explains directly observed therapy, and the importance of taking all medications for the prescribed period of time.
Favorite
2002
This pamphlet uses a question and answer format to provide information on TB infection, how it is transmitted and diagnosed, what to do when a skin test is positive, and what a person needs to know about TB medicines.
Favorite
Persons With LTBI
2002
This pamphlet uses a question and answer format to provide information about coinfection with tuberculosis (TB) and the human immunodeficiency virus (HIV).
Favorite
Persons With LTBI
2002
This report summarizes the accomplishments and activities of the Stop TB Partnership in 2001.
Favorite
Community Leaders
2002
This report sets out the rationale for the ProTest Initiative (Promotion of Voluntary Testing), based on an analysis of the impact of HIV on TB control. It describes the elements of the ProTest approach, reviews progress so far, and sets out the future direction. The purpose of the report is to generate discussion and ideas that will help the Initiative establish a comprehensive range of interventions needed to control TB in settings with high prevalence of HIV infection.
Favorite
Policy Makers
2002
This book discusses targeted tuberculin skin testing for latent TB infection as a strategic component of TB control. Specifically addressed are how to administer, read, and interpret the tuberculin skin test and its specificity and sensitivity.
Favorite
2002
This report, based upon current available scientific knowledge and medical practice, provides information to the medical community concerned with the care of individuals with tuberculosis and/or HIV/AIDS.
Favorite
2002
This fact sheet discusses the correlation between TB and poverty. It lists the steps in fighting TB and poverty, and states that DOTS is a global strategy to fight TB and alleviate poverty and inequity.
Favorite
2002
This fact sheet explains that DOTS can reduce household poverty by averting (1) the loss of income, (2) the cost of inadequate treatment, (3) the socio-economic costs of coping by families, (4) malnutrition, and (5) death.
Favorite
2002
This fact sheet discusses the risk groups who are more vulnerable to TB and why these groups are most at risk. The at-risk groups includeing the urban poor, migrants, and refugees, the homeless, prisoners, and people living with HIV/AIDS.
Favorite
2002
This fact sheet reviews the history of World TB Day and lists past years' themes. It also discusses the aims of 2002's theme "Stop TB, Fight Poverty" launched by the Stop TB Partnership to start a five year campaign.
Favorite
Health Educators/Communicators
International Agencies
2002
This report is a statement of the Advisory Council for the Elimination of Tuberculosis (ACET) that examines the challenges to TB control in current low-incidence areas and offers recommendations for meeting those challenges. The purpose of this statement is to inform federal, state, and local public health officials, health-policy makers, and the general health-care community about the unique challenges of TB control and about the roles each can play to ensure progress toward elimination in those areas where the disease is becoming increasingly uncommon.
Favorite
Policy Makers
2002
This Power Point slide set presents basic TB information for the general public. The presentation stresses the difference between latent TB infection and active TB disease, how TB is spread, and how to prevent it.
Favorite
2002
This report describes community-based tuberculosis care in Latin America, and field visits to selected community-based TB care projects to understand the origin, performance, acceptability, effectiveness, and sustainability of some existing DOTS projects. Three sites in Colombia and two in Bolivia, where the DOTS strategy is already implemented, were visited...
Favorite
Community Leaders
Managers and Supervisors
2002
This straight-edge ruler is used to measure the induration of an individual's reaction to the tuberculin skin test. The white ruler provides tips on how to read the test and a space for local contact information to be inscribed with a permanent marker.
Favorite
2002
